Dolph Denny
Interventional Cardiology · Madisonville, KYNPI 1164419917
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,045 of the $7,326 with a category attached, or 68.9%. Boehringer Ingelheim accounts for 69.9% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2019 at $6,681 and has fallen 98.9% since, to $77 in 2025. That places this record below the midpoint for interventional cardiology clinicians in KY, where the typical reported total is $7,951.
Across 146 payments — averaging $50.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$5K
- Johnson & Johnson$300
- Astellas Pharma US Inc$223
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$202
- Sanofi-aventis U.S. LLC$162
- Amgen$160
- plus $1K from 24 others
What the payments were for
- Speaking & faculty fees$5,04569%
- Travel & lodging$160%
- Food & beverage$2,07528%
- Education$1903%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 10 | $5,122 |
| Johnson & Johnson | 31 | $300 |
| Astellas Pharma US Inc | 4 | $223 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $202 |
| Sanofi-aventis U.S. LLC | 11 | $162 |
| Amgen | 11 | $160 |
| AstraZeneca | 9 | $156 |
| Abbott | 7 | $154 |
| Novartis | 8 | $129 |
| Lundbeck LLC | 5 | $94 |
| Regeneron Healthcare Solutions, Inc. | 5 | $88 |
| Amarin Pharma, Inc. | 5 | $80 |
| Bayer | 3 | $55 |
| E.r. Squibb & Sons, L.L.C. | 2 | $45 |
| United Therapeutics Corporation | 3 | $45 |
| Pfizer | 3 | $39 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Cardinal Health 200 LLC | 2 | $29 |
| Chiesi USA, Inc. | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Boston Scientific | 1 | $21 |
| Kestra Medical Technology Services, Inc. | 1 | $20 |
| Medtronic | 1 | $19 |
| Shockwave Medical, Inc | 1 | $17 |
| Gilead | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Novo Nordisk | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,326 in reported general payments places this provider in the 45th percentile of 129 interventional cardiology providers in Kentucky.
Other interventional cardiology in Madisonville
- Amit SrivastavaEdgewood$642K
- Avichai EresLexington$616K
- Steve LinLexington$362K
- Daniel StewartLouisville$290K
- Robert SawyerLexington$249K
- Ganesh Keshav ThirunavukkarasuLexington$220K
- Daniel RothschildLouisville$154K
- Naresh SolankhiLouisville$132K
- Ashish RastogiOwensboro$123K
- Armaghan SoomroLexington$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.